Cite

HARVARD Citation

    Ferreri, A. et al. (n.d.). CLARITHROMYCIN AS a "REPURPOSING DRUG" AGAINST LYMPHOMAS: SAFETY AND EFFICACY PROFILES IN 55 PATIENTS WITH EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL). Hematological oncology. pp. 86-87. [Online]. 
  
Back to record